Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
4.77 USD 0.00(0%)
Last update at 2026-11-17T21:00:00Z
VOLUME
194792
Market Cap
390.05M
P/E
14.24

Momentum Score

…

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans; and dental and vision insurance plans. It also sells medicines. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.48
Low
4.81
High
52 Week Price Range
4.46
Low
7.39
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Auna S.A. is a Peru-based integrated healthcare operator that provides hospital, outpatient and preventive health services to individual and corporate clients. Long-term growth may be supported by demographic aging, rising private healthcare consumption and expansion of service and insurance offerings, which could support revenue diversification and margin improvement. Investors may find the company attractive for its scale in private healthcare and exposure to secular increases in health spending.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.77
Dividend Yield
-
Revenue TTM
4385.30M
Revenue Per Share
59.10
Gross Profit TTM
1663.71M
Debt / Equity
2.28
ROE
6.54%
Net Debt
3320.29M
ROCE
9.75%
Diluted EPS TTM
0.37

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 187.82M 184.52M -124.17M -47.45M -3.13M
Minority interest - -13.69M -39.58M -8.78M -3.45M
Net income 92.01M 110.72M -253.92M -85.61M -26.47M
Selling general administrative - 788.68M 653.67M 477.08M 416.78M
Selling and marketing expenses - 129.03M 123.70M 109.58M 107.10M
Gross profit 1568.26M 1637.46M 1435.35M 879.70M 686.93M
Reconciled depreciation - 219.15M 235.75M 138.09M 77.39M
Ebit 548.73M 708.09M 411.55M 161.05M 92.75M
Ebitda 758.40M 928.12M 647.30M 299.14M 170.15M
Depreciation and amortization 209.67M 220.03M 235.75M 138.09M 77.39M
Operating income 548.73M 708.17M 560.34M 254.59M 108.14M
Other operating expenses 3584.96M 3695.63M 3315.57M 2197.02M 1815.58M
Interest expense 613.92M 484.10M 535.72M 208.50M 95.88M
Tax provision - 59.82M 90.17M 29.38M 19.90M
Interest income - 21.09M 16.96M 6.88M 1.75M
Net interest income - -508.75M -606.50M -208.85M -98.40M
Income tax expense 83.28M 60.06M 90.17M 29.38M 19.90M
Total revenue 4133.69M 4403.80M 3875.91M 2451.61M 1923.72M
Total operating expenses 1019.53M 929.29M 875.01M 625.12M 578.79M
Cost of revenue 2565.43M 2766.34M 2440.56M 1571.90M 1236.78M
Total other income expense net -360.91M -523.66M -684.51M -302.03M -111.27M
Net income from continuing ops - 123.96M -214.34M -76.83M -23.02M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 7297.41M 7080.72M 7689.55M 6593.66M 2823.65M
Intangible assets - 902.60M 1059.95M 953.03M 325.03M
Other current assets 258.49M 262.25M 223.45M 324.66M 118.68M
Total liab 5531.21M 5457.78M 5912.99M 5035.60M 2277.74M
Total stockholder equity 1600.62M 1477.22M 1465.29M 1064.98M 495.82M
Other current liab 267.95M 226.83M 385.35M 227.26M 179.18M
Common stock 17.39M 17.39M 8.82M 236.55M 236.55M
Capital stock - 17.39M 8.82M 236.55M 236.55M
Retained earnings 414.50M -273.53M -366.90M -90.98M -45.49M
Good will 2704.11M 1754.29M 2069.24M 1805.89M 184.96M
Other assets 0.00M - -5612.75M - 0.00M
Cash 335.41M 235.75M 241.13M 208.69M 138.77M
Total current liabilities 1666.94M 1945.28M 1689.31M 2845.12M 698.49M
Current deferred revenue 0.10M - 40.12M 12.01M 0.33M
Net debt 3320.29M 3531.92M 3678.49M 3302.88M 1354.26M
Short term debt 345.59M 686.69M 417.17M 2069.06M 46.61M
Short long term debt - 654.23M 385.30M 2040.98M 29.73M
Short long term debt total 3655.70M 3767.66M 3919.63M 3511.57M 1493.03M
Other stockholder equity 1209.61M 1208.59M - 386.05M 386.05M
Total current assets 1844.39M 1703.87M 1549.15M 1195.10M 671.27M
Long term investments - 25.69M 20.87M 13.10M 14.29M
Short term investments 30.23M 100.23M 93.13M 0.00M 0.00M
Net receivables 1055.48M 961.89M 860.92M 574.17M 352.66M
Long term debt - 2965.54M 3376.28M 1307.67M 1322.71M
Inventory 164.78M 143.76M 130.52M 87.58M 61.15M
Accounts payable 1053.30M 931.26M 749.35M 512.59M 454.10M
Accumulated other comprehensive income -40.88M 524.78M 1823.36M 533.37M -81.28M
Non currrent assets other 26.91M 89.57M 110.44M 39.88M 163.41M
Non current assets total 5453.02M 5376.85M 6140.40M 5398.57M 2152.38M
Capital lease obligations - 147.89M 158.04M 162.92M 140.58M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -236.82M -173.15M -3209.44M -291.99M
Total cashflows from investing activities -78.83M -236.82M - - -
Net borrowings - 68.27M - - -
Total cash from financing activities -74.31M -418.12M -370.00M 3130.65M -102.13M
Net income 92.01M 123.96M -214.34M -76.83M -23.02M
Change in cash 124.43M -5.39M 32.44M 69.92M -204.68M
Begin period cash flow 210.98M 241.13M 208.69M 138.77M 343.45M
End period cash flow 335.41M 235.75M 241.13M 208.69M 138.77M
Total cash from operating activities 242.83M 668.50M 582.41M 162.64M 183.34M
Issuance of capital stock - 1267.79M - - -
Depreciation 209.67M 219.15M 235.75M 138.09M 77.39M
Other cashflows from investing activities -19.93M -98.79M - - -
Dividends paid - 1.15M 6.84M 0.13M 0.00M
Change to inventory -16.82M -25.85M -30.11M -22.91M -10.78M
Change to account receivables -76.95M -343.15M -316.00M -80.48M -39.47M
Other cashflows from financing activities -145.14M -1753.03M -671.18M 1217.84M -105.21M
Capital expenditures 81.08M 90.86M 165.16M 151.97M 289.37M
Change in working capital -49.07M -172.57M -141.63M -174.45M 49.03M
Stock based compensation - 9.14M 3.67M 0.00M 0.00M
Other non cash items -9.78M 429.00M 608.79M 246.45M 60.05M
Free cash flow 161.76M 577.64M 417.25M 10.67M -106.03M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AUNA
Auna S.A.
-
-%
4.77 14.24 - 0.09 0.81 1.08 4.41
HCA
HCA Healthcare, Inc.
-11.35
2.22%
500.43 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
-
-%
282.07 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
-0.01
0.07%
14.78 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
-
-%
5.57 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

Auna S.A.

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans; and dental and vision insurance plans. It also sells medicines. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

6, rue Jean Monnet, Luxembourg, Luxembourg, 2180

51 1 205 3500

14605

Name Title Year Born
Mr. Jesús Zamora Leon President, CEO & Executive Chairman of the Board 1963
Ms. Gisele Remy Ferrero CFO & Executive VP NA
Mr. Marco Roca Executive VP of Regional Operations & Country Representative of Peru NA
Mr. Andres Angel Executive VP of AunaWay implementation & Country Representative in Colombia NA
Mr. Sven Boes Executive VP of Regional Healthcare Services & Country Representative of Mexico NA
Mr. Laurent Massart Executive VP of Strategy & Equity Capital Markets NA
Mr. Jesús Antonio Zamora Leon President, CEO & Executive Chairman of the Board 1964
Ms. Gisele Remy Ferrero CFO & Executive VP 1980
Ms. Rayet Harb Executive Vice President Operations 1973
Mr. Laurent Massart Executive VP of Strategy & Equity Capital Markets 1968

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…